Association of advanced glycation end-product accumulation with overactive bladder in community-dwelling elderly: A cross-sectional Sukagawa study

Association of advanced glycation end-product accumulation with overactive bladder in community-dwelling elderly: A cross-sectional Sukagawa study

Objective: This study aimed to evaluate the influence of advanced glycation end-product (AGE) accumulation on the prevalence and severity of overactive bladder (OAB) in community-dwelling elderly adults. Methods: We conducted a cross-sectional study involving 269 Japanese community dwellers aged ≥75...

Full description

Saved in:

Bibliographic Details
Main Authors:	Kenji Omae, Noriaki Kurita, Sei Takahashi, Shingo Fukuma, Yosuke Yamamoto, Shunichi Fukuhara
Format:	Article
Language:	English
Published:	Elsevier 2021-04-01
Series:	Asian Journal of Urology
Subjects:	Advanced glycation end-products Elderly Overactive bladder Skin autofluorescence Urinary incontinence
Online Access:	http://www.sciencedirect.com/science/article/pii/S2214388220300254
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Overactive Bladder: Where We Are and Where We Are Going
by: Charan S. Mohan, et al.
Published: (2021-09-01)

Guidelines for the Treatment of Urinary Incontineence and Overactive Bladder
by: C.F. Heyns, et al.
Published: (2002-03-01)

Efficacy and safety of solifenacin for overactive bladder: An updated systematic review and meta-analysis
by: I Gede Yogi Prema Ananda, et al.
Published: (2025-01-01)

Acupuncture combined with mirabegron is efficacious for the treatment of overactive bladder: a prospective randomized controlled trial
by: Deng Xiaolin, et al.
Published: (2025-07-01)

Risk factors, urodynamic characteristics, and distress associated with nocturnal enuresis in overactive bladder -wet women
by: Kuan Chong Ng, et al.
Published: (2025-01-01)

The role of Kegel exercises in reducing involuntary loss of urine in Overactive Bladder and Mixed Urinary Inconti-nence
by: Lucian Șerbanescu, et al.
Published: (2025-01-01)

Intradetrusor OnabotulinumtoxinA outcomes for overactive bladder in older adults
by: Rachel Stading, et al.
Published: (2024-12-01)

Outcome of post‐prostatectomy stress urinary incontinence surgery in men with preoperative idiopathic detrusor overactivity
by: Nikita R. Bhatt, et al.
Published: (2024-11-01)

Parameters which predict detrusor overactivity after adjustable trans obturator male system (ATOMS) implant.
by: Miguel Vírseda-Chamorrro, et al.
Published: (2025-06-01)

Effects of Glucagon like Peptide-1 agonists on patients with overactive bladder: A pilot study
by: Max D. Sandler, et al.
Published: (2025-06-01)

Mirabegron in the Management of Overactive Bladder Syndrome in Ghazi Al-Hariri Hospital
by: Hiba H. Razaq, et al.
Published: (2025-04-01)

Prevalence, impact on quality of life, and predictive factors of coexistence of overactive bladder and underactive bladder in men
by: Noritoshi Sekido, et al.
Published: (2025-07-01)

Expert Opinions on Best Practices for Overactive Bladder Management with onabotulinumtoxinA
by: Karyn S. Eilber, et al.
Published: (2025-04-01)

Application of methylene blue as an improvement of the injection technique of botulinum toxin A in the treatment of refractory idiopathic overactive bladder: prospective, single-blind (patient-blind), randomized trial
by: Michał Szczypior, et al.
Published: (2019-02-01)

Does local vaginal estrogen after tension-free transobturator vaginal tape reduce overactive bladder symptoms in postmenopausal women? A prospective randomized, controlled study
by: Samer Mahmoud Morsy, et al.
Published: (2024-01-01)

The Effects of Suburethral Tension Adjustable Sling (Remeex system) for Female Urinary Incontinence between Pure Intrinsic Sphincter Deficiency and Intrinsic Sphincter Deficiency with Overactive Bladder: Initial Experience with Propensity Score Matching
by: Sang Wook Lee, et al.
Published: (2022-08-01)

Neuromodulation – a therapeutic option for refractory overactive bladder. A recent literature review
by: Jacek K. Szymański, et al.
Published: (2019-05-01)

Skin Autofluorescence–Indicated Advanced Glycation End Products as Predictors of Cardiovascular and All‐Cause Mortality in High‐Risk Subjects: A Systematic Review and Meta‐analysis
by: Ivan Cavero‐Redondo, et al.
Published: (2018-09-01)

Global insights into overactive bladder management: A survey of physician preferences and practices
by: Omer Anis, et al.
Published: (2025-09-01)

Health utility value of overactive bladder in Japanese older adults
by: Takashi Yoshioka, et al.
Published: (2025-01-01)

The efficacy of parasacral transcutaneous electrical nerve stimulation for the treatment of overactive bladder in children: a systematic review and meta-analysis
by: Zhuoqi Cheng, et al.
Published: (2025-01-01)

Intravesical Onabotulinum Toxin A Injection Paradigms for Idiopathic Overactive Bladder: A Scoping Review of Clinical Outcomes, Techniques, and Implications for Practice and Future Research
by: Ekene Enemchukwu, et al.
Published: (2025-04-01)

Prospective Study of Change in Skin Autofluorescence Over Time and Mortality in People Receiving Hemodialysis
by: Daniela Viramontes-Hörner, et al.
Published: (2024-07-01)

Disparities in surgical treatments for stress, urge and mixed urinary incontinence: Evidence from the 2019 National Ambulatory Surgery Sample (NASS)
by: Christabel Egemba, et al.
Published: (2025-03-01)

The associations between skin advanced glycation end-products and Framingham cardiovascular risk in different age groups
by: Yina Wang, et al.
Published: (2025-04-01)

Does Anticholinergic Burden Influence Therapeutic Success in Patients with Treatment-naïve Overactive Bladder?
by: João Oliveira, et al.
Published: (2025-09-01)

Efficacy of Combined Therapy With Silodosin and Solifenacin in Females With Overactive Bladder
by: Byeong Jo Jeon, et al.
Published: (2024-12-01)

Neurotrophins and Proneurotrophins as Biomarkers for Overactive Bladder Syndrome in Aging Females
by: Claudia Covarrubias, et al.
Published: (2025-06-01)

The Role of microRNA in Overactive Bladder: Relationship and Clinical Correlation
by: Kürşat Küçüker, et al.
Published: (2025-03-01)

Outcomes of Sacral Neuromodulation and Intradetrusor Onabotulinum Toxin in the Management of Stroke Associated Urinary Incontinence
by: Tyler Trump, et al.
Published: (2025-03-01)

Mindfulness and Transcranial Direct Current Stimulation (tDCS) to Attenuate Situational Urgency Urinary Incontinence (UUI): A randomized pilot study
by: Cynthia A. Conklin, et al.
Published: (2025-06-01)

Sacral neuromodulation for urinary incontinence
by: Tyler Trump, et al.
Published: (2024-12-01)

Comparison Of Outcome And Side Effects Profile Of Treatment Of Overactive Bladder With Different Classes Of Drugs
by: Nazish Sarfraz, et al.
Published: (2023-12-01)

Transvertebral magnetic neuromodulation for the treatment of overactive bladder: 6 months follow-up
by: G V. Kovalev, et al.
Published: (2020-12-01)

Etude du profil de glycation et ses caractéristiques chez les diabétiques type 2 en Algérie [Study of the glycation profile and Its characteristics in algerian type 2 diabetic patients ]
by: Sarra Chine, et al.
Published: (2025-06-01)

Individualizing medical treatment of overactive bladder
by: Hann-Chorng Kuo
Published: (2018-01-01)

EFFICACY OF EXTRACORPOREAL ELECTROMAGNETIC STIMULATION FOR THE TREATMENT OF URINARY INCONTINENCE AND THE PREDICTIVE FACTORS FOR SATISFACTION
by: Funda Güngör Uğurlucan, et al.
Published: (2024-03-01)

New insights into the association between arthritis and overactive bladder in NHANES 2005–2020
by: Yifan Sun, et al.
Published: (2025-02-01)

The clinical application of intravesical botulinum toxin A injection in patients with overactive bladder and interstitial cystitis
by: Yuan-Hong Jiang, et al.
Published: (2023-01-01)

The Management of Children and Adolescents with Overactive Bladder Refractory to Treatment with Parasacral Transcutaneous Electrical Nerve Stimulation
by: Carlos Eduardo Rocha Macedo, et al.
Published: (2025-01-01)